177 related articles for article (PubMed ID: 28177944)
1. Metformin depresses overactivated Notch1/Hes1 signaling in colorectal cancer patients with type 2 diabetes mellitus.
Yang B; Huang CZ; Yu T; Zhou SN; Liu Q; Liu GJ; Chen S; Han FH
Anticancer Drugs; 2017 Jun; 28(5):531-539. PubMed ID: 28177944
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Notch1/Hes1 signaling pathway improves radiosensitivity of colorectal cancer cells.
Zhang H; Jiang H; Chen L; Liu J; Hu X; Zhang H
Eur J Pharmacol; 2018 Jan; 818():364-370. PubMed ID: 29126793
[TBL] [Abstract][Full Text] [Related]
3. [Metformin can reduce the risk of colorectal cancer].
Fransgård T; Gögenur I
Ugeskr Laeger; 2015 May; 177(21):V12140659. PubMed ID: 26027593
[TBL] [Abstract][Full Text] [Related]
4. Effects of metformin on CD133+ colorectal cancer cells in diabetic patients.
Zhang Y; Guan M; Zheng Z; Zhang Q; Gao F; Xue Y
PLoS One; 2013; 8(11):e81264. PubMed ID: 24278407
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer.
Al Omari A; Abdelkhaleq H; Al-Hussaini M; Turfa R; Awad N; Hassan MM; Alfaqih MA; Garrett CR
J Glob Oncol; 2018 Jul; 4():1-10. PubMed ID: 30084749
[TBL] [Abstract][Full Text] [Related]
6. The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus.
Tarhini Z; Manceur K; Magne J; Mathonnet M; Jost J; Christou N
Sci Rep; 2022 Jul; 12(1):12374. PubMed ID: 35859114
[TBL] [Abstract][Full Text] [Related]
7. Metformin and Colorectal Cancer - A Systematic Review.
Kobiela J; Dobrzycka M; Jędrusik P; Kobiela P; Spychalski P; Śledziński Z; Zdrojewski T
Exp Clin Endocrinol Diabetes; 2019 Jul; 127(7):445-454. PubMed ID: 29954001
[TBL] [Abstract][Full Text] [Related]
8. Metformin: A Salutary Candidate for Colorectal Cancer Treatment in Patients with Diabetes.
Samuel VP; Dahiya R; Singh Y; Gupta G; Sah SK; Gubbiyappa SK; Chellappan DK; Dua K
J Environ Pathol Toxicol Oncol; 2019; 38(2):133-141. PubMed ID: 31679276
[TBL] [Abstract][Full Text] [Related]
9. Effects of diabetes type 2 and metformin treatment in Swedish patients with colorectal cancer.
Dimberg J; Shamoun L; Landerholm K; Wågsäter D
World J Gastroenterol; 2022 May; 28(19):2148-2151. PubMed ID: 35664033
[TBL] [Abstract][Full Text] [Related]
10. MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.
Spitschak A; Meier C; Kowtharapu B; Engelmann D; Pützer BM
Mol Cancer; 2017 Jan; 16(1):24. PubMed ID: 28122586
[TBL] [Abstract][Full Text] [Related]
11. Abnormal differentiation of intestinal epithelium and intestinal barrier dysfunction in diabetic mice associated with depressed Notch/NICD transduction in Notch/Hes1 signal pathway.
Min XH; Yu T; Qing Q; Yuan YH; Zhong W; Chen GC; Zhao LN; Deng N; Zhang LF; Chen QK
Cell Biol Int; 2014 Oct; 38(10):1194-204. PubMed ID: 24890925
[TBL] [Abstract][Full Text] [Related]
12. Pien Tze Huang inhibits the proliferation, and induces the apoptosis and differentiation of colorectal cancer stem cells via suppression of the Notch1 pathway.
Qi F; Wei L; Shen A; Chen Y; Lin J; Chu J; Cai Q; Pan J; Peng J
Oncol Rep; 2016 Jan; 35(1):511-7. PubMed ID: 26530025
[TBL] [Abstract][Full Text] [Related]
13. Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer.
Garrett CR; Hassabo HM; Bhadkamkar NA; Wen S; Baladandayuthapani V; Kee BK; Eng C; Hassan MM
Br J Cancer; 2012 Apr; 106(8):1374-8. PubMed ID: 22421948
[TBL] [Abstract][Full Text] [Related]
14. Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients.
Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
World J Gastroenterol; 2017 Jul; 23(28):5196-5205. PubMed ID: 28811714
[TBL] [Abstract][Full Text] [Related]
15. Sirt3 promotes the autophagy of HK‑2 human proximal tubular epithelial cells via the inhibition of Notch‑1/Hes‑1 signaling.
Wang Y; Chang J; Wang ZQ; Li Y
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278469
[TBL] [Abstract][Full Text] [Related]
16. Paeoniflorin influences breast cancer cell proliferation and invasion via inhibition of the Notch‑1 signaling pathway.
Zhang J; Yu K; Han X; Zhen L; Liu M; Zhang X; Ren Y; Shi J
Mol Med Rep; 2018 Jan; 17(1):1321-1325. PubMed ID: 29115554
[TBL] [Abstract][Full Text] [Related]
17. Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus.
Saito A; Kitayama J; Horie H; Koinuma K; Ohzawa H; Yamaguchi H; Kawahira H; Mimura T; Lefor AK; Sata N
Cancer Sci; 2020 Nov; 111(11):4012-4020. PubMed ID: 32794612
[TBL] [Abstract][Full Text] [Related]
18. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
[TBL] [Abstract][Full Text] [Related]
19. Antiandrogen abiraterone and docetaxel treatments affect Notch1, Jagged1 and Hes1 expressions in metastatic prostate cancer cells.
Soylu H; Kırca M; Avcı S; Ozpolat B; Ustunel I
Exp Mol Pathol; 2021 Apr; 119():104607. PubMed ID: 33482170
[TBL] [Abstract][Full Text] [Related]
20. Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes.
Chen CH; Lin CL; Hsu CY; Kao CH
QJM; 2020 Mar; 113(3):194-200. PubMed ID: 31593243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
